Omada Health announces GLP-1 prescribing capability

Omada Health (OMDA) announced the planned launch of its prescribing capability, adding an option for prescribing and medication management of anti-obesity medications, including GLP-1s, to its weight health program. “Between provider visits is when real life happens and where outcomes are determined,1,2 and we believe Omada is uniquely positioned to offer support throughout the whole care journey,” said Thomas Tsang, chief medical officer at Omada Health. “This new capability will provide coordinated care as members start, stay on, or transition from AOMs. We also plan to continue enhancing this experience by building on our integration of AI-enabled support tools.”